Table 3.
Factors associated with treatment outcome (cure) at 8 and 10 weeks
| Variable | Crude OR (95% CI) 8 weeks | P value | Crude OR | P value |
|---|---|---|---|---|
| 8 weeks | (95% CI) 10 weeks | 10 weeks | ||
| Sex | ||||
| Females | 1.930 (0.997–3.738) | 0.050* | 2.444 (1.248–4.788) | 0.009* |
| Males | 1 | – | 1 | – |
| Type of lesion | ||||
| Papule | 2.731 (1.292–5.774) | 0.009* | 2.746 (1.260–5.982) | 0.012* |
| Nodule | 0.756 (0.323–1.772) | 0.520 | 0.985 (0.451–2.151) | 0.969 |
| Ulcer | 0.125 (0.125–3.446) | 0.618 | 0.738 (0.166–3.285) | 0.691 |
| Nodular ulcer | 1 | – | 1 | – |
| Size | ||||
| < 2 cm | 1.953 (0.983–3.871) | 0.050* | 1.861 (0.978–3.542) | 0.050* |
| > 2 cm | 1 | – | 1 | – |
| Treatment | ||||
| Thermotherapy | 2.236 (1.217–4.108) | 0.012* | 1.881 (1.044–3.388) | 0.032* |
| IL-SSG | 1 | – | 1 | – |
IL-SSG = intralesional sodium stibogluconate. Factors that likely influence cure were analyzed using binary logistic regression. Odds ratio (OR) and confidence interval (CI) were calculated for each variable.
*
P value less than 0.05 was taken as significant.